Rameda commences manufacture of “Anviziram” Tablets the Generic Equivalent of Japanese antiviral Avigan for treatment of Covid-19 patients and receives approval from Egyptian Drug Authority to manufacture Remedsivir Corporate NewsBy adminJune 22, 2020
Rameda values the role played by the Egyptian Pharmacists Syndicate and Pharmacies in serving patients across Egypt Corporate NewsBy adminApril 28, 2020
Rameda issues statement regarding the “Stay Home to Protect your Family and Community” initiative Corporate NewsBy adminApril 28, 2020
Rameda launches initiative for the complementary dispensary and home delivery of medication at no cost, underlining its dedication to ensuring the healthcare and safety of some of Egypt’s most immune-compromised patient populations amid the COVID-19 pandemic Corporate NewsBy adminApril 26, 2020
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Acquires A Large Generic Product in a Sizable and Fast-Growing Therapeutic Area Corporate NewsBy adminApril 1, 2020
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Reports double-digit topline growth in FY19 and major facility upgrades & expansions completed during the year Corporate NewsBy adminFebruary 18, 2020
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Announced Indicative Results for FY2019 Corporate NewsBy adminJanuary 26, 2020
